Trade discount for chief distributors requires a real commercial distinction; higher valuation discount claim was rejected.

For valuation of pharmaceutical products, a higher trade discount for chief distributors was rejected because the assessee failed to establish a commercial distinction between chief distributors and other distributors, or any contractual requirement for a minimum monthly purchase justifying differential treatment. The Tribunal applied the same reasoning as in the assessee's earlier matter and held that, without proof of a real and commercially justified basis for a separate discount, the higher discount could not be allowed. The order confirming the valuation and penalty was sustained.

---

---

Issues: Whether the appellants were entitled to claim a higher discount on sales to chief distributors while determining the assessable value of the pharmaceutical products, and whether the impugned order confirming limitation of discount and penalty was sustainable.

Analysis: The Tribunal noted that in an earlier final order concerning the same assessee, it had been held that no distinction was established between chief distributors and other distributors, and that there was no proof that a chief distributor was required to buy a specified monthly quantity so as to justify a higher discount. The same reasoning applied to the present case.

Conclusion: The higher discount claim was rejected and the impugned order was upheld.

Final Conclusion: The appeal failed and the order confirming the duty valuation and penalty stood sustained.

Ratio Decidendi: A higher trade discount for a class of buyers is not allowable for valuation purposes unless the assessee establishes a real and commercially justified distinction supporting that differential discount.

---